Omalizumab treatment in 2 cases of refractory heat urticaria

Journal of Investigational Allergology and Clinical Immunology

Volumn 23, Issue 7, 2013, Pages 519-521

  Carballada, Francisco ^a   Nunez R ^a   Martin Lazaro J ^a   Juarez Y ^a   Castineira I ^a   Fernandez L ^a   Boquete, M ^a  

^a HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

Author keywords

Angioedema; Anti ige; Heat urticaria; Omalizumab; Quality of life

Indexed keywords

DEFLAZACORT; EBASTINE; FEXOFENADINE; HYDROXYZINE; IMMUNOGLOBULIN E; LEVOCETIRIZINE; MONTELUKAST; OMALIZUMAB; PREDNISONE;

ADULT; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; CASE REPORT; DAILY LIFE ACTIVITY; DRUG DOSE REDUCTION; ERYTHEMA; FEMALE; HEAT URTICARIA; HUMAN; INTRACUTANEOUS TEST; NOTE; PHOTOPATCH TEST; PRICK TEST; PROVOCATION TEST; PRURITUS; SINGLE DRUG DOSE; SKIN EDEMA; THERMAL EXPOSURE; URTICARIA;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HOT TEMPERATURE; HUMANS; MIDDLE AGED; URTICARIA;

EID: 84890061126     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Bullerkotte U, Wieczored D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010 Jul;65(7):931-2.
2. Koh YI, Choi IS, Lee SH, Lee JB, Park CH, Hong SN. Localized heat urticaria associated with mast cell and eosinophil degranulation. J Allergy Clin Immunol. 2002 Apr;109(4):714-5.
3. Fukunaga A, Shimoura S, Fukunaga M, Ueda M, Nagai H, Bito T, Tsuru K, Ichihashi M, Horokawa T. Localized heat urticaria in a patient is associated with a wealing response to heated autologous serum. Br J Dermatol. 2002 Nov;147(5):994-7.
4. Ferrer M, Gamboa P, Sanz ML, Goikoetxea MJ, Cabrera-Freitag P, Javaloyes G, Berroa F, Kaplan AP. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May;127(5):1300-2.
5. Nam YH, Kim JH, Jin HJ, Hwang EK, Shin YS, Ye YM, Park HS. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy Asthma Immunol Res. 2012 Nov;4(6):357-61.
6. Ivyanskiy I, Sand C, Thomsen SF. Omalizumab for chronic urticaria: a case series and overview of the literature. Case Rep Dermatol. 2012 Jan;4(1):19-26.
7. Saavedra MC, Sur S. Down regulation of the high-affi nity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy. 2011 Jan 19;9(1):2.
8. Saini S, Rosen KE, Hsieh HJDA, Conner E, Kaplan A, Spector S, Maurer M. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep;128(3):567-73.
9. Rodríguez-Trabado A, Fernández Pereira LM, Romero-Chala S, García-Trujillo JA, Cámara Hijón C. Monitoring omalizumab treatment effi cacy in chronic urticaria by the basophil activation test. Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2.
10. Büyüköztürk S, Gelincik A, Demirtürk M, Kocaturk E, Colakolu B, Dal M. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol. 2012 May;39(5):439-42.